Search research articles
Contact Us
Filters
Showing results (571-580 of 674) with videos related to
Page
of 68
Sort By:
The Oncologist
|
May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
Sara M Tolaney, David R Ziehr, Hao Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 12, 2013
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy
Lee W Jones, Diane R Fels, Miranda West, et al.
International Journal of Cancer
|
November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer
Andrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M Tolaney, Yves Boucher, Dan G Duda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901
Vanessa B Sheppard, Leigh Anne Faul, George Luta, et al.
Cancer Research
|
January 9, 2020
Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, et al.
NPJ Breast Cancer
|
September 27, 2017
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design
Jennifer A Ligibel, William T Barry, Catherine Alfano, et al.
Nature Immunology
|
November 24, 2020
MEK inhibition reprograms CD8<sup>+</sup> T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, et al.
Cancer Research
|
October 21, 2016
mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
David R Driscoll, Saadia A Karim, Makoto Sano, et al.
Cancer Research
|
July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer
Alissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Page
of 68
Search research articles
Search
Showing results (571-580 of 674) with videos related to
Sort By:
Page
of 68
The Oncologist
|
May 12, 2021
Phase II and Biomarker Study of Cabozantinib in Metastatic Triple-Negative Breast Cancer Patients
Sara M Tolaney, David R Ziehr, Hao Guo, et al.
Cancer Prevention Research (Philadelphia, Pa.)
|
July 12, 2013
Modulation of circulating angiogenic factors and tumor biology by aerobic training in breast cancer patients receiving neoadjuvant chemotherapy
Lee W Jones, Diane R Fels, Miranda West, et al.
International Journal of Cancer
|
November 13, 2019
Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer
Andrea P Myers, Panagiotis A Konstantinopoulos, William T Barry, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 19, 2015
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M Tolaney, Yves Boucher, Dan G Duda, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 18, 2014
Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901
Vanessa B Sheppard, Leigh Anne Faul, George Luta, et al.
Cancer Research
|
January 9, 2020
Combined MEK and PI3K/p110β Inhibition as a Novel Targeted Therapy for Malignant Mesothelioma Displaying Sarcomatoid Features
Miriam Marqués, Robin Tranchant, Blanca Risa-Ebrí, et al.
NPJ Breast Cancer
|
September 27, 2017
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design
Jennifer A Ligibel, William T Barry, Catherine Alfano, et al.
Nature Immunology
|
November 24, 2020
MEK inhibition reprograms CD8<sup>+</sup> T lymphocytes into memory stem cells with potent antitumor effects
Vivek Verma, Nazli Jafarzadeh, Shannon Boi, et al.
Cancer Research
|
October 21, 2016
mTORC2 Signaling Drives the Development and Progression of Pancreatic Cancer
David R Driscoll, Saadia A Karim, Makoto Sano, et al.
Cancer Research
|
July 18, 2024
Targeting Cholesterol Biosynthesis with Statins Synergizes with AKT Inhibitors in Triple-Negative Breast Cancer
Alissandra L Hillis, Timothy D Martin, Haley E Manchester, et al.
Page
of 68